Theralase Technologies Stock Market Capitalization
| TLT Stock | CAD 0.28 0.01 3.70% |
Theralase Technologies fundamentals help investors to digest information that contributes to Theralase Technologies' financial success or failures. It also enables traders to predict the movement of Theralase Stock. The fundamental analysis module provides a way to measure Theralase Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theralase Technologies stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 35.6 M | 23.4 M |
Theralase | Market Capitalization |
Theralase Technologies Company Market Capitalization Analysis
Theralase Technologies' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Theralase Technologies Market Capitalization | 66.3 M |
Most of Theralase Technologies' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theralase Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Theralase Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Theralase Technologies is extremely important. It helps to project a fair market value of Theralase Stock properly, considering its historical fundamentals such as Market Capitalization. Since Theralase Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theralase Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theralase Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Theralase Technologies is about 66.3 M. This is 99.49% lower than that of the Health Care Equipment & Supplies sector and 99.4% lower than that of the Health Care industry. The market capitalization for all Canada stocks is 99.65% higher than that of the company.
Theralase Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theralase Technologies' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theralase Technologies could also be used in its relative valuation, which is a method of valuing Theralase Technologies by comparing valuation metrics of similar companies.Theralase Technologies is currently under evaluation in market capitalization category among its peers.
Theralase Technologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theralase Technologies from analyzing Theralase Technologies' financial statements. These drivers represent accounts that assess Theralase Technologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theralase Technologies' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 38.8M | 77.6M | 66.5M | 39.6M | 35.6M | 23.4M | |
| Enterprise Value | 31.0M | 74.0M | 65.5M | 39.9M | 35.9M | 21.8M |
Theralase Fundamentals
| Return On Equity | -2.39 | ||||
| Return On Asset | -0.82 | ||||
| Operating Margin | (11.30) % | ||||
| Current Valuation | 68.13 M | ||||
| Shares Outstanding | 245.54 M | ||||
| Shares Owned By Insiders | 8.70 % | ||||
| Number Of Shares Shorted | 42.79 K | ||||
| Price To Earning | (9.79) X | ||||
| Price To Book | 31.86 X | ||||
| Price To Sales | 74.01 X | ||||
| Revenue | 1.07 M | ||||
| Gross Profit | 628.17 K | ||||
| EBITDA | (4.31 M) | ||||
| Net Income | (4.57 M) | ||||
| Cash And Equivalents | 1.67 M | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 386.88 K | ||||
| Current Ratio | 3.45 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (4.07 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.2 | ||||
| Beta | 1.35 | ||||
| Market Capitalization | 66.3 M | ||||
| Total Asset | 3.28 M | ||||
| Retained Earnings | (63.24 M) | ||||
| Working Capital | 421.43 K | ||||
| Net Asset | 3.28 M |
About Theralase Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theralase Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theralase Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theralase Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.